Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Pharma Giant GSK To Expand In Montgomery Co., Investing $800 Million
GSK will invest $800 million to expand its Upper Merion facility in Montgomery County, Pennsylvania, creating a new manufacturing hub and 300 new jobs.
Will Skyrizi and Rinvoq Drive AbbVie's Top-Line Growth in Q3 Earnings?
AbbVie prepares to report Q3 2026 results, with investors focused on whether Skyrizi and Rinvoq can sustain growth and offset Humira's declining sales.
Biotech Rebound Reality: Surging M&A Deals Meet Deep Retail Skepticism
Biotechnology stocks are recovering due to a surge in M&A deals by big pharma, despite persistent caution and deep skepticism from retail investors.
Early Alzheimer's Biomarker Test Results Boost Certainty & Clinical Care
Earlier disclosure of Alzheimer's blood test results significantly increased diagnostic certainty and guided clinical care without raising patient anxiety.
Tortugas Phase IIb Schizophrenia Trial of Obuprazine Meets Key Endpoints
Tortugas Neuroscience and Hansoh Pharma report that their Phase IIb trial of obuprazine for acute schizophrenia successfully met its primary endpoint.
CAR-T specialist Caribou culls pipeline and seeks exit deal
Caribou Biosciences is discontinuing its allogeneic CAR-T pipeline, laying off staff, and seeking an exit deal amid shifting investor focus to in vivo approaches.
Lacosamide protected cartilage in preclinical tests — ScienceDaily
Yale researchers discovered that the epilepsy drug lacosamide may reduce pain and prevent cartilage damage in osteoarthritis during preclinical tests.
10x Genomics and Fred Hutch partner on cancer technologies
10x Genomics and Fred Hutch partnered to advance single cell and spatial platforms in solid tumors and hematologic malignancies, including AML.
Teva wins FDA approval for monthly schizophrenia injection Weltruza
The FDA has approved Teva's Weltruza, a once-monthly olanzapine injection developed with Medincell, for the treatment of adults with schizophrenia.
FDA Grants Breakthrough Device Designation to Natera’s Multi-Cancer Early Detection
The FDA granted Breakthrough Device Designation to Natera’s cell-free DNA multi-cancer early detection assay after reviewing data from 12 cancer types.
Lakewood-Amedex Announces Positive Preclinical Bisphosphocin Compound Data
Lakewood-Amedex reported positive preclinical data for its Bisphosphocin compounds, demonstrating potent antimicrobial activity against UTI and lung infections.
FDA Accepts NDA for Bezuclastinib in the Treatment of Advanced SM Disease
The FDA has accepted the NDA for Cogent Biosciences' bezuclastinib to treat advanced systemic mastocytosis, based on strong Phase 2 APEX trial results.
2
3
4
5
6
7
8
9
10